The effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell
Cancer Science, 07/11/2012
Liu J et al. – The results demonstrated that the G250–specific oncolytic adenovirus expressing Ki67–siRNA is applicable for human renal clear cell cancer therapy.



